Glucocorticoids, developmental 'programming' and the risk of affective dysfunction

Progress in Brain Research

Volumn 167, Issue , 2007, Pages 17-34

  Seckl, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase type 2; anxiety; epigenetic; glucocorticoid; glucocorticoid receptor; hypothalamic pituitary adrenal; intergenerational; PTSD; stress

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID;

BIRTH WEIGHT; BRAIN DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEARNING; MOOD DISORDER; NEUROPSYCHIATRY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; STRESS;

ANIMALS; BEHAVIOR; BRAIN; BRAIN DISEASES; GLUCOCORTICOIDS; HUMANS; MOOD DISORDERS;

EID: 36248940166     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(07)67002-2     Document Type: Review

References (169)

1. Alati R., Lawlor D.A., Al Mamun A., Williams G.M., Najman J.M., O'Callaghan M., and Bor W. Is there a fetal origin of depression? Evidence from the Mater University Study of Pregnancy and its outcomes. Am. J. Epidemiol. 165 5 (2007) 575-582
2. Albiston A.L., Obeyesekere V.R., Smith R.E., and Krozowski Z.S. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105 2 (1994) R11-R17
3. Antonow-Schlorke I., Schwab M., Li C., and Nathanielsz P.W. Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J. Physiol. Lond. 547 1 (2003) 117-123
4. Baird J., Osmond C., MacGregor A., Snieder H., Hales C., and Phillips D. Testing the fetal origins hypothesis in twins: the Birmingham twin study. Diabetologia 44 (2001) 33-39
5. Barker D.J.P. Fetal and infant origins of adult disease (1991), BMJ, London
6. Barker D.J.P., Gluckman P.D., Godfrey K.M., Harding J.E., Owens J.A., and Robinson J.S. Fetal nutrition and cardiovascular disease in adult life. Lancet 341 (1993) 938-941
7. Barker D.J.P., Hales C.N., Fall C.H.D., Osmond C., Phipps K., and Clarke P.M.S. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36 (1993) 62-67
8. Bavdekar A., Yajnik C.S., Fall C.H., Bapat S., Pandit A.N., Deshpande V., Bhave S., Kellingray S.D., and Joglekar C. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?. Diabetes 48 12 (1999) 2422-2429
9. Benediktsson R., Brennand J., Tibi L., Calder A.A., Seckl J.R., and Edwards C.R.W. Fetal osteocalcin levels are related to placental 11β-hydroxysteroid dehydrogenase activity. Clin. Endocrinol. 42 (1995) 551-555
10. Benediktsson R., Calder A.A., Edwards C.R.W., and Seckl J.R. Placental 11β-hydroxysteroid dehydrogenase type 2 is the placental barrier to maternal glucocorticoids: ex vivo studies. Clin. Endocrinol. 46 (1997) 161-166
11. Benediktsson R., Lindsay R., Noble J., Seckl J.R., and Edwards C.R.W. Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet 341 (1993) 339-341
12. Berkowitz G.S., Wolff M.S., Janevic T.M., Holzman I.R., Yehuda R., and Landrigan P.J. The World Trade Center disaster and intrauterine growth restriction. JAMA 290 5 (2003) 595-596
13. Bertram C., Trowern A.R., Copin N., Jackson A.A., and Whorwood C.B. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 142 7 (2001) 2841-2853
14. Bhattacharyya, S., Brown, D., Brewer, J., Vogt, S. and Muglia, L. (2007) Macrophage glucocorticoid receptors regulate toll-like receptor-4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood (Epub: http://www.bloodjournal.org/cgi/reprint/blood-2006-10-048215v1).
15. Bloom S.L., Sheffield J.S., McIntire D.D., and Leveno K.J. Antenatal dexamethasone and decreased birth weight. Obstet. Gynecol. 97 4 (2001) 485-490
16. Bohn M.C. Granule cell genesis in the hippocampus of rats treated neonatally with hydrocortisone. Neuroscience 5 (1980) 2003-2012
17. Bremner J.D., Randall P., Scott T.M., Bronen R.A., Seibyl J.P., Southwick S.M., Delaney R.C., McCarthy G., Charney D.S., and Innis R.B. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder [comment]. Am. J. Psychiatry 152 7 (1995) 973-981
18. Brown R.W., Diaz R., Robson A.C., Kotelevtsev Y., Mullins J.J., Kaufman M.H., and Seckl J.R. The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137 (1996) 794-797
19. Brown R.W., Kotolevtsev Y., Leckie C., Lindsay R.S., Lyons V., Murad P., Mullins J.J., Chapman K.E., Edwards C.R.W., and Seckl J.R. Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA. Biochem. J. 313 (1996) 1007-1017
20. Buss C., Lord C., Wadiwalla M., Hellhammer D.H., Lupien S.J., Meaney M.J., and Pruessner J.C. Maternal care modulates the relationship between prenatal risk and hippocampal volume in women but not in men. J. Neurosci. 27 10 (2007) 2592-2595
21. Canlon B., Erichsen S., Nemlander E., Chen M., Hossain A., Celsi G., and Ceccatelli S. Alterations in the intrauterine environment by glucocorticoids modifies the development programme of the auditory system. Eur. J. Neurosci. 17 10 (2003) 2035-2041
22. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 159 7 (2002) 1080-1092
23. Catalani A., Marinelli M., Scaccianoce S., Nicolai R., Muscolo L.A.A., Porcu A., Koranyi L., Piazza P.V., and Angelucci L. Progeny of mothers drinking corticosterone during lactation has lower stress-induced corticosterone secretion and better cognitive performance. Brain Res. 624 (1993) 209-215
24. Champagne F.A., Weaver I.C.G., Diorio J., Dymov S., Szyf M., and Meaney M.J. Maternal care associated with methylation of the estrogen receptor-alpha 1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology 147 6 (2006) 2909-2915
25. Clark P.M., Hindmarsh P.C., Shiell A.W., Law C.M., Honour J.W., and Barker D.J.P. Size at birth and adrenocortical function in childhood. Clin. Endocrinol. 45 (1996) 721-726
26. Cleasby M.E., Kelly P.A.T., Walker B.R., and Seckl J.R. Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids. Endocrinology 144 3 (2003) 999-1007
27. Cole T., Blendy J.A., Monaghan A.P., Kriegelstein K., Schmid W., Fantuzzi G., Hummler E., Unsicker K., and Schütz G. Targeted disruption of the glucocorticoid receptor blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9 (1995) 1608-1621
28. Cole T.J. Cloning of the mouse 11beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136 (1995) 4693-4696
29. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., and Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell-development and severely retards lung maturation. Genes Dev. 9 13 (1995) 1608-1621
30. Cole T.J., Blendy J.A., Monaghan A.P., Schmid W., Aguzzi A., and Schutz G. Molecular genetic analysis of glucocorticoid signaling during mouse development. Steroids 60 (1995) 93-96
31. Costello E.J., Worthman C., Erkanli A., and Angold A. Prediction from low birth weight to female adolescent depression - a test of competing hypotheses. Arch. Gen. Psychiatry 64 3 (2007) 338-344
32. Cratty M.S., Ward H.E., Johnson E.A., Azzaro A.J., and Birkle D.L. Prenatal stress increases corticotropin-releasing factor (Crf) content and release in rat amygdala minces. Brain Res. 675 1-2 (1995) 297-302
33. Curhan G.C., Chertow G.M., Willett W.C., Spiegelman D., Colditz G.A., Manson J.E., Speizer F.E., and Stampfer M.J. Birth-weight and adult hypertension and obesity in women. Circulation 94 (1996) 1310-1315
34. Curhan G.C., Willett W.C., Rimm E.B., Spiegelman D., Ascherio A.L., and Stampfer M.J. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 94 (1996) 3246-3250
35. Dave-Sharma S., Wilson R.C., Harbison M.D., Newfield R., Azar M., Krozowski Z.S., Funder J.W., Shackleton C.H.L., Bradlow H.L., Wei J.Q., Hertecant J., Moran A., Neiberger R.E., Balfe J.W., Fattah A., Daneman D., Akkurt H.I., DeSantis C., and New M.I. Extensive personal experience - examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 83 (1998) 2244-2254
36. Diaz R., Brown R.W., and Seckl J.R. Ontogeny of mRNAs encoding glucocorticoid and mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenases in prenatal rat brain development reveal complex control of glucocorticoid action. J. Neurosci. 18 (1998) 2570-2580
37. Diaz R., Fuxe K., and Ogren S.O. Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats. Neuroscience 81 (1997) 129-140
38. Diaz R., Ögren S.O., Blum M., and Fuxe K. Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats. Neuroscience 66 (1995) 467-473
39. Dodic M., Hantzis V., Duncan J., Rees S., Koukoulas I., Johnson K., Wintour E.M., and Moritz K. Programming effects of short prenatal exposure to cortisol. FASEB J. 16 9 (2002) 1017-1026
40. Dodic M., May C.N., Wintour E.M., and Coghlan J.P. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci. 94 (1998) 149-155
41. Dodic M., Moritz K., Koukoulas I., and Wintour E.M. Programmed hypertension: kidney, brain or both?. Trends Endocrinol. Metab. 13 9 (2002) 403-408
42. Dodic M., Peers A., Coghlan J., May C., Lumbers E., Yu Z., and Wintour E. Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin. Sci. 97 (1999) 103-109
43. Doyle L.W., Ford G.W., Davis N.M., and Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin. Sci. 98 (2000) 137-142
44. Drake A.J., Walker B.R., and Seckl J.R. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (2005) R34-R38
45. Dunn A., and Berridge C. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses. Brain Res. Rev. 15 (1990) 71-100
46. Edwards C.R.W., Benediktsson R., Lindsay R., and Seckl J.R. Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension?. Lancet 341 (1993) 355-357
47. Encio I.J., and Detera-Wadleigh S.D. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266 (1991) 7182-7188
48. Engel S.M., Berkowitz G.S., Wolff M.S., and Yehuda R. Psychological trauma associated with the World Trade Center attacks and its effect on pregnancy outcome. Paediatr. Perinat. Epidemiol. 19 5 (2005) 334-341
49. Fall C.H.D., Osmond C., Barker D.J.P., Clark P.M.S., Hales C.N., Stirling Y., and Meade T.W. Fetal and infant growth and cardiovascular risk factors in women. Br. Med. J. 310 (1995) 428-432
50. Famularo R., and Fenton T. Early developmental history and pediatric posttraumatic-stress-disorder. Arch. Pediatr. Adolesc. Med. 148 10 (1994) 1032-1038
51. Feldman S., and Weidenfeld J. The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res. Bull. 45 (1998) 389-393
52. Forest M.G., David M., and Morel Y. Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 45 (1993) 75-82
53. Forsen T., Eriksson J.G., Tuomilehto J., Teramo K., Osmond C., and Barker D.J.P. Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. Br. Med. J. 315 (1997) 837-840
54. French N.P., Hagan R., Evans S.F., Godfrey M., and Newnham J.P. Repeated antenatal corticosteroids: size at birth and subsequent development. Am. J. Obstet. Gynecol. 180 1 Pt 1 (1999) 114-121
55. Fumagalli F., Jones S.R., Caron M.G., Seidler F.J., and Slotkin T.A. Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res. 719 (1996) 225-228
56. Fuxe K., Wikstrom A.-C., Okret S., Agnati L.F., Harfstrand A., Yu Z.-Y., Granholm L., Zoli M., Vale W., and Gustafsson J.-A. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinol. 117 (1985) 1803-1812
57. Gatford K.L., Wintour E.M., de Blasio M.J., Owens J.A., and Dodic M. Differential timing for programming of glucose homoeostasis, sensitivity to insulin and blood pressure by in utero exposure to dexamethasone in sheep. Clin. Sci. 98 (2000) 553-560
58. Goland R.S., Jozak S., Warren W.B., Conwell I.M., Stark R.I., and Tropper P.J. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J. Clin. Endocrinol. Metab. 77 (1993) 1174-1179
59. Goland R.S., Tropper P.J., Warren W.B., Stark R.I., Jozak S.M., and Conwell I.M. Concentrations of corticotropin-releasing hormone in the umbilical-cord blood of pregnancies complicated by preeclampsia. Reprod. Fertil. Dev. 7 (1995) 1227-1230
60. Gould E., Woolley C.S., Cameron H.A., Daniels D.C., and McEwen B.S. Adrenal steroids regulate postnatal development in the rat dentate gyrus: II. Effects of glucocorticoids on cell birth. J. Comp. Neurol. 313 (1991) 486-493
61. Gould E., Woolley C.S., and McEwen B.S. Adrenal steroids regulate postnatal development in the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J. Comp. Neurol. 313 (1991) 479-485
62. Hawkins P., Steyn C., McGarrigle H.H., Calder N.A., Saito T., Stratford L.L., Noakes D.E., and Hanson M.A. Cardiovascular and hypothalamic-pituitary-adrenal axis development in late gestation fetal sheep and young lambs following modest maternal nutrient restriction in early gestation. Reprod. Fertil. Dev. 12 7-8 (2000) 443-456
63. Holmes M., Sangra M., French K., Whittle I., Paterson J., Mullins J., and Seckl J. 11beta-hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids. Neurosci. 137 (2005) 865-873
64. Holmes M.C., Abrahamsen C.T., French K.L., Paterson J.M., Mullins J.J., and Seckl J.R. The mother or the fetus? 11 beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J. Neurosci. 26 14 (2006) 3840-3844
65. Hsu D., Chen F., Takahashi L., and Kalin N. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res. 788 (1998) 305-310
66. Huang W.L., Beazley L.D., Quinlivan J.A., Evans S.F., Newnham J.P., and Dunlop S.A. Effect of corticosteroids on brain growth in fetal sheep. Obstet. Gynecol. 94 2 (1999) 213-218
67. Huang W.L., Harper C.G., Evans S.F., Newnham J.P., and Dunlop S.A. Repeated prenatal corticosteroid administration delays astrocyte and capillary tight junction maturation in fetal sheep. Int. J. Dev. Neurosci. 19 5 (2001) 487-493
68. Huang W.L., Harper C.G., Evans S.F., Newnham J.P., and Dunlop S.A. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int. J. Dev. Neurosci. 19 4 (2001) 415-425
69. Ikegami M., Jobe A.H., Newnham J., Polk D.H., Willet K.E., and Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am. J. Respir. Crit. Care Med. 156 1 (1997) 178-184
70. Irving R.J., Belton N.R., Elton R.A., and Walker B.R. Adult cardiovascular risk factors in premature babies. Lancet 355 (2000) 2135-2136
71. Jacobson L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenal axis. Endocrinol. Rev. 12 (1991) 118-134
72. Jensen E.C., Gallaher B.W., Breier B.H., and Harding J.E. The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep. J. Endocrinol. 174 1 (2002) 27-36
73. Jones P.B., Rantakallio P., Hartikainen A.L., Isohanni M., and Sipila P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 North Finland general population birth cohort. Am. J. Psychiatry 155 3 (1998) 355-364
74. Kitraki E., Kittas C., and Stylianopoulou F. Glucocorticoid receptor gene expression during rat embryogenesis. An in situ hybridization study. Differentiation 62 (1997) 21-31
75. Koenig J.I., Kirkpatrick B., and Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27 2 (2002) 309-318
76. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev. 25 2 (2001) 117-142
77. Kotelevtsev Y., Brown R.W., Fleming S., Kenyon C.J., Edwards C.R.W., Seckl J.R., and Mullins J.J. Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J. Clin. Invest. 103 (1999) 683-689
78. Langley-Evans S.C. Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J. Hypertens. 15 (1997) 537-544
79. Langley-Evans S.C., Gardner D.S., and Jackson A.A. Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. J. Nutr. 126 (1996) 1578-1585
80. Langley-Evans S.C., Philips G., Benediktsson R., Gardner D., Edwards C.R.W., Jackson A.A., and Seckl J.R. Maternal dietary protein restriction, placental glucocorticoid metabolism and the programming of hypertension. Placenta 17 (1996) 169-172
81. Law C.M., Shiell A.W., Newsome C.A., Syddall H.E., Shinebourne E.A., Fayers P.M., Martyn C.N., and de Swiet M. Fetal, infant, and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age. Circulation 105 9 (2002) 1088-1092
82. Leon D.A., Koupilova I., Lithell H.O., Berglund L., Mohsen R., Vagero D., Lithell U.B., and McKeigue P.M. Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. Br. Med. J. 312 (1996) 401-406
83. Lesage J., Blondeau B., Grino M., Breant B., and Dupouy J.P. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology 142 5 (2001) 1692-1702
84. Levine R.S., Hennekens C.H., and Jesse M.J. Blood pressure in prospective population based cohort of newborn and infant twins. Br. Med. J. 308 (1994) 298-302
85. Levine S. Infantile experience and resistance to physiological stress. Science 126 (1957) 405-406
86. Levine S. Plasma-free corticosteroid response to electric shock in rats stimulated in infancy. Science 135 (1962) 795-796
87. Levitt N., Lindsay R.S., Holmes M.C., and Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64 (1996) 412-418
88. Levitt N.S., Lambert E.V., Woods D., Hales C.N., Andrew R., and Seckl J.R. Impaired glucose tolerance and elevated blood pressure in low birth weight, non-obese young South African adults: early programming of the cortisol axis. J. Clin. Endocrinol. Metab. 85 (2000) 4611-4618
89. Lillycrop K.A., Phillips E.S., Jackson A.A., Hanson M.A., and Burdge G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr. 135 6 (2005) 1382-1386
90. Lindsay R.S., Lindsay R.M., Edwards C.R.W., and Seckl J.R. Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27 (1996) 1200-1204
91. Lindsay R.S., Lindsay R.M., Waddell B., and Seckl J.R. Programming of glucose tolerance in the rat: role of placental 11β-hydroxysteroid dehydrogenase. Diabetologia 39 (1996) 1299-1305
92. Lithell H.O., McKeigue P.M., Berglund L., Mohsen R., Lithell U.B., and Leon D.A. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Br. Med. J. 312 (1996) 406-410
93. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., Sharma S., Pearson D., Plotsky P.M., and Meaney M.J. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277 (1997) 1659-1662
94. Lopez Bernal A., and Craft I.L. Corticosteroid metabolism in vitro by human placenta, foetal membranes and decidua in early and late gestation. Placenta 2 (1981) 279-285
95. Lopez Bernal A., Flint A.P.F., Anderson A.B.M., and Turnbull A.C. 11β-hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua. J. Steroid Biochem. 13 (1980) 1081-1087
96. MacArthur B.A., Howie R.N., Dezoete J.A., and Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 70 1 (1982) 99-105
97. Matthews S.G. Antenatal glucocorticoids and programming of the developing CNS. Pediatr. Res. 47 3 (2000) 291-300
98. McCormick C.M., Smythe J.W., Sharma S., and Meaney M.J. Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Dev. Brain Res. 84 (1995) 55-61
99. McCormick, J., Lyons, V., Jacobson, M., Diorio, J., Nyirenda, M., Weaver, S., J.L.W., Ester, W., Meaney, M.J., Seckl, J.R. and Chapman, K.E. (2000) 5′-heterogeneity of glucocorticoid receptor mRNA is tissue-specific: differential regulation of variant promoters by early life events. Mol. Endocrinol., 14: 506-517.
100. McTernan C.L., Draper N., Nicholson H., Chalder S.M., Driver P., Hewison M., Kilby M.D., and Stewart P.M. Reduced placental 11 beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J. Clin. Endocrinol. Metab. 86 10 (2001) 4979-4983
101. Meaney M.J., Aitken D.H., van Berkel C., Bhatnagar S., and Sapolsky R.M. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 239 (1988) 766-768
102. Meaney M.J., Aitken D.H., Sharma S., and Viau V. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and hippocampal corticosteroid receptors in young and aged, handled and non-handled rats. Neuroendocrinology 55 (1992) 204-213
103. Meaney M.J., Aitken D.H., Viau V., Sharma S., and Sarrieau A. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinol. 50 (1989) 597-604
104. Meaney M.J., Diorio J., Francis D., Weaver S., Yau J.L.W., Chapman K.E., and Seckl J.R. Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hormones and serotonin. J. Neurosci. 20 (2000) 3926-3935
105. Meaney M.J., Diorio J., Francis D., Widdowson J., LaPlante P., Caldji C., Sharma S., Seckl J.R., and Plotsky P.M. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Dev. Neurosci. 18 (1996) 49-72
106. Mercado A.B., Wilson R.C., Cheng K.C., Wei J.Q., and New M.I. Prenatal treatment and diagnosis of congential adrenal hyperlasia owing to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 80 (1995) 2014-2020
107. Meyer J.S. Early adrenalectomy stimulates subsequent growth and development of the rat brain. Exp. Neurol. 82 (1983) 432-446
108. Mitchell J.B., Rowe W., Boksa P., and Meaney M.J. Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures. J. Neurosci. 10 (1990) 1745-1752
109. Moore V.M., Miller A.G., Boulton T.J.C., Cockington R.A., Craig I.H., Magarey A.M., and Robinson J.S. Placental weight, birth measurements, and blood pressure at age 8 years. Arch. Dis. Child. 74 (1996) 538-541
110. Murphy V.E., Zakar T., Smith R., Giles W.B., Gibson P.G., and Clifton V.L. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J. Clin. Endocrinol. Metab. 87 4 (2002) 1660-1668
111. Newnham J.P., Evans S.F., Godfrey M., Huang W., Ikegami M., and Jobe A. Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J. Matern. Fetal Med. 8 3 (1999) 81-87
112. Newnham J.P., and Moss T.J. Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies. Semin. Neonatol. 6 4 (2001) 285-292
113. Nyirenda M., Dean S., Lyons V., Chapman K., and Seckl J. Prenatal programming of hepatocyte nuclear factor 4 alpha in the rat: a key mechanism in the 'fetal origins of hyperglycemia'?. Diabetologia 49 (2006) 1412-1420
114. Nyirenda M.J., Lindsay R.S., Kenyon C.J., Burchell A., and Seckl J.R. Glucocorticoid exposure in late gestation permanently programmes rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest. 101 (1998) 2174-2181
115. Osmond C., Barker D.J.P., Winter P.D., Fall C.H.D., and Simmonds S.J. Early growth and death from cardiovascular disease in women. Br. Med. J. 307 (1993) 1524-1527
116. Pepin M.C., Pothier F., and Barden N. Impaired glucocorticoid receptor function in transgenic mice expressing antisense RNA. Nature 355 (1992) 725-728
117. Phillips D.I., Fall C.H.D., Whorwood C.B., Seckl J.R., Wood P.J., Barker D.J.P., and Walker B.R. Elevated plasma cortisol concentrations: an explanation for the relationship between low birthweight and adult cardiovascular risk factors. J. Clin. Endocrinol. Metab. 83 (1998) 757-760
118. Phillips D.I.W., Walker B.R., Reynolds R.M., Flanagan D.E.H., Wood P.J., Osmond C., Barker D.J.P., and Whorwood C.B. Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 35 6 (2000) 1301-1306
119. Reinisch J.M., Simon N.G., Karwo W.G., and Gandelman R. Prenatal exposure to prednisone in humans and animals retards intra-uterine growth. Science 202 (1978) 436-438
120. Reynolds R.M., Walker B.R., Syddall H.E., Andrew R., Wood P.J., Whorwood C.B., and Phillips D.I.W. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 86 (2001) 245-250
121. RichEdwards J.W., Stampfer M.J., Manson J.E., Rosner B., Hankinson S.E., Colditz G.A., Willett W.C., and Hennekens C.H. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br. Med. J. 315 (1997) 396-400
122. Robson A.C., Leckie C., Seckl J.R., and Holmes M.C. Expression of 11β-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Mol. Brain Res. 61 (1998) 1-10
123. Rogerson F.M., Kayes K., and White P.C. No correlation in human placenta between activity or mRNA for the K (type 2) isozyme of 11β-hydroxysteroid dehydrogenase and fetal or placental weight. Tenth Int. Congr. Endocrinol. Abstr. P1-231 (1996) 193
124. Rogerson F.M., Kayes K.M., and White P.C. Variation in placental type 2 11beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol. Cell. Endocrinol. 128 (1997) 103-109
125. Seckl J.R. Physiologic programming of the fetus. Clin. Perinatol. 25 (1998) 939-964
126. Seckl J.R., and Meaney M.J. Glucocorticoid programming. Biobehav. Stress Response Prot. Damag. Eff. 1032 (2004) 63-84
127. Shams M., Kilby M.D., Somerset D.A., Howie A.J., Gupta A., Wood P.J., Afnan M., and Stewart P.M. 11beta hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth retardation. Hum. Reprod. 13 (1998) 799-804
128. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3908-3913
129. Slotkin T.A., Barnes G.A., McCook E.C., and Seidler F.J. Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Dev. Brain Res. 93 (1996) 155-161
130. Smythe J.W., Rowe W.B., and Meaney M.J. Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. Dev. Brain Res. 80 (1994) 183-189
131. Speirs H., Seckl J., and Brown R. Ontogeny of glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. J. Endocrinol. 181 (2004) 105-116
132. St Clair D., Xu M.Q., Wang P., Yu Y.Q., Fang Y.R., Zhang F., Zheng X.Y., Gu N.F., Feng G.Y., Sham P., and He L. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294 5 (2005) 557-562
133. Stein M.B., Koverola C., Hanna C., Torchia M.G., and McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol. Med. 27 4 (1997) 951-959
134. Stewart P.M., Murry B.A., and Mason J.I. Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab. 78 (1994) 1529-1532
135. Stewart P.M., Rogerson F.M., and Mason J.I. Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J. Clin. Endocrinol. Metab. 80 (1995) 885-890
136. Sugden M.C., Langdown M.L., Munns M.J., and Holness M.J. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur. J. Endocrinol. 145 4 (2001) 529-539
137. Sun K., Yang K., and Challis J.R.G. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. J. Clin. Endocrinol. Metab. 82 (1997) 300-305
138. Susser E., Neugebauer R., Hoek H.W., Brown A.S., Lin S., Labovitz D., and Gorman J.M. Schizophrenia after prenatal famine. Arch. Gen. Psychiatry 53 (1996) 25-31
139. Susser E.S., and Lin S.P. Schizophrenia after prenatal exposure to the Dutch hunger winter of 1944-1945. Arch. Gen. Psychiatry 49 12 (1992) 983-988
140. Thapar A., Langley K., Fowler T., Rice F., Turic D., Whittinger N., Aggleton J., Van den Bree M., Owen M., and O'Donovan M. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 62 11 (2005) 1275-1278
141. Thomassin H., Flavin M., Espinas M., and Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J. 20 (2001) 1974-1983
142. Thompson C., Syddall H., Rodin I., Osmond C., and Barker D.J.P. Birth weight and the risk of depressive disorder in late life. Br. J. Psychiatry 179 (2001) 450-455
143. Trautman P.D., Meyer-Bahlburg H.F.L., Postelnek J., and New M.I. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinol. 20 (1995) 439-449
144. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., and Schütz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23 (1999) 99-103
145. Turner J.D., and Muller C.P. Structure of the glucocorticoid receptor (NR3C1) gene 5′ untranslated region: identification, and tissue distribution of multiple new human exon 1. J. Mol. Endocrinol. 35 2 (2005) 283-292
146. Uno H., Eisele S., Sakai A., Shelton S., Baker E., DeJesus O., and Holden J. Neurotoxicity of glucocorticoids in the primate brain. Horm. Behav. 28 (1994) 336-348
147. Uno H., Lohmiller L., Thieme C., Kemnitz J.W., Engle M.J., Roecker E.B., and Farrell P.M. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Dev. Brain Res. 53 (1990) 157-167
148. Venihaki M.A., Carrigan P., Dikkes P., and Majzoub J. Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 7336-7341
149. de Vries A., Holmes M., Heijnis A., Seier J., van Heerden J., Louw J., Wolfe-Coote S., Meaney M., Levitt N., and Seckl J. Prenatal dexamethasone exposure induces changes in offspring cardio-metabolic and hypothalamic-pituitary-adrenal axis function without alteration of birth weight in a non-human primate, the African vervet, Chlorocebus aethiops. J. Clin. Invest. 117 (2007) 1058-1067
150. Waddell B., Benediktsson R., Brown R., and Seckl J.R. Tissue-specific mRNA expression of 11B-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggest exquisite local control of glucocorticoid action. Endocrinology 139 (1998) 1517-1523
151. Waddell B.J., and Atkinson H.C. Production rate, metabolic clearance rate and uterine extraction of corticosterone during rat pregnancy. J. Endocrinol. 143 (1994) 183-190
152. Ward R.M. Pharmacologic enhancement of fetal lung maturation. Clin. Perinatol. 21 (1994) 523-542
153. Weaver I., Cervoni N., Champagne F., D'Alessio A., Sharma S., Seckl J., Dymov S., Szyf M., and Meaney M. Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004) 847-854
154. Weaver I.C.G., D'Alessio A.C., Brown S.E., Hellstrom I.C., Dymov S., Sharma S., Szyf M., and Meaney M.J. The transcription factor nerve growth factor-inducible protein A mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J. Neurosci. 27 7 (2007) 1756-1768
155. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 65 (2001) 427-451
156. Weinstock M., Matlina E., Maor G.I., Rosen H., and McEwen B.S. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res. 595 (1992) 195-200
157. Welberg L.A.M., and Seckl J.R. Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 13 (2001) 113-128
158. Welberg L.A.M., Seckl J.R., and Holmes M.C. Inhibition of 11β-hydroxysteroid dehydrogenase, the feto-placental barrier to maternal glucocorticoids, permanently programs amygdala glucocorticoid receptor mRNA expression and anxiety-like behavior in the offspring. Eur. J. Neurosci. 12 (2000) 1047-1054
159. Welberg L.A.M., Seckl J.R., and Holmes M.C. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 104 (2001) 71-79
160. White P.C., Mune T., and Agarwal A.K. 11beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrinol. Rev. 18 (1997) 135-156
161. Wiles N.J., Peters T.J., Leon D.A., and Lewis G. Birth weight and psychological distress at age 45-51 years-results from the Aberdeen Children of the 1950s cohort study. Br. J. Psychiatry 187 (2005) 21-28
162. Yajnik C.S., Fall C.H.D., Vaidya U., Pandit A.N., Bavdekar A., Bhat D.S., Osmond C., Hales C.N., and Barker D.J.P. Fetal growth and glucose and insulin metabolism in four-year- old Indian children. Diabet. Med. 12 (1995) 330-336
163. Yau J.L.W., Noble J., and Seckl J.R. Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following methylenedioxymethamphetamine: role of corticosterone and serotonin. Neuroscience 78 (1997) 111-121
164. Yau J.L.W., Noble J., Widdowson J., and Seckl J.R. Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus. Mol. Brain Res. 45 (1997) 182-186
165. Yeh T., Lin Y., Lin H., Huang C., Hsieh W., Lin C., and Tsai C. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 350 (2004) 1304-1313
166. Yehuda R. Current concepts: post-traumatic stress disorder. N. Engl. J. Med. 346 2 (2002) 108-114
167. Yehuda R., Engel S.M., Brand S.R., Seckl J., Marcus S.M., and Berkowitz G.S. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J. Clin. Endocrinol. Metab. 90 7 (2005) 4115-4118
168. Yehuda R., Golier J.A., Yang R.K., and Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 55 11 (2004) 1110-1116
169. Yehuda R., Teicher M., Seckl J., Grossman R., Morris A., and Bierer L. Parental PTSD is a 'vulnerability' factor for low cortisol trait in offspring of Holocaust survivors. Arch. Gen. Psychiatry, 64 9 (2007) 1040-1048